NCT00568984 - Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes | Biotech Hunter

Enrollment

324

Participants

Timeline

Start Date

November 21, 2002

Primary Completion Date

November 10, 2003

Study Completion Date

November 10, 2003

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

repaglinide

DRUG

metformin

DRUG

glicazide

Trial Locations (15)

1003

Novo Nordisk Investigational Site, Manila

1100

Novo Nordisk Investigational Site, Quezon City

1800

Novo Nordisk Investigational Site, Marikina City

2000

Novo Nordisk Investigational Site, Pampanga

4301

Novo Nordisk Investigational Site, Quezon

6000

Novo Nordisk Investigational Site, Cebu City

10300

Novo Nordisk Investigational Site, Bangkok

10330

Novo Nordisk Investigational Site, Bangkok

16150

Novo Nordisk Investigational Site, Kota Bharu, Kelantan

30450

Novo Nordisk Investigational Site, Ipoh

56000

Novo Nordisk Investigational Site, Cheras

100034

Novo Nordisk Investigational Site, Beijing

100044

Novo Nordisk Investigational Site, Beijing

100730

Novo Nordisk Investigational Site, Beijing

300052

Novo Nordisk Investigational Site, Tianjin